Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02304419
Title A Study of Galunisertib on the Immune System in Participants With Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

Therapies

Galunisertib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center New York City New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field